This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health. The $234,000 award will support a study by the University of Colorado-Denver, which will measure levels of delta 9-tetrahydrocannabinol (D9-THC) and cannabidiol (CBD) in maternal serum and umbilical cord blood to assess associations with...
The federal Project Grant award K23DA060336, provided by the National Institute on Drug Abuse (NIDA), will fund a study on the prevalence and effects of cannabidiol (CBD) use during pregnancy. The project falls under NIDA's Drug Use and Addiction Research Programs (CFDA 93.279), which supports research aimed at understanding and addressing substance use disorders. The study, to be conducted by the University of Colorado-Denver, will have three main objectives: 1) Estimate the prevalence of CBD...
The National Institute on Drug Abuse (NIDA) awarded a $390,635 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Pittsburgh to develop a novel intervention targeting prenatal depressive symptoms to encourage tobacco and cannabis cessation among marginalized pregnant individuals. The project aims to: (1) conduct formative research to understand the relationship between depressive symptoms and prenatal dual use of tobacco and cannabis; (2) co-create an...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $102,961 to Brown University to develop a toolkit that enables U.S. healthcare providers to adopt a harm reduction approach when discussing perinatal cannabis use with patients. The key products and services to be delivered under this 2-year grant, which runs from July 2024 to June 2026, include: Conducting a core components analysis of an existing Canadian...
This $510,492 federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to the University of Maryland, College Park aims to examine maternal health outcomes and the impact of state policies expanding public insurance coverage for non-qualified immigrant populations before, during, and after pregnancy. Specifically, the research project will: 1) analyze differences in severe maternal...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $443,263 to Rutgers, The State University for a 5-year study on the relationship between cannabis use and sleep in women of childbearing age. The project aims to characterize the effect of recreational cannabis use on sleep patterns, brain activity, and stress physiology in this population, including how these factors may be influenced by...
This federal Project Grant award, valued at $1,744,696.00 and awarded by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control, is intended to support the "ASSESSING THE IMPLEMENTATION AND OUTCOMES OF STATE PRENATAL DRUG USE LAWS" research project under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The primary awardee, The Johns Hopkins University, will lead this 3-year research effort to...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $126,442 to the University of Maryland, Baltimore to investigate the effects of prenatal exposure to delta-9-tetrahydrocannabinol (THC) on the development and function of cannabinoid type-1 receptors (CB1Rs) in the primary visual cortex of ferrets. The research aims to determine if prenatal THC exposure leads to initial decreases followed...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to study the impact of adolescent cannabis use on prefrontal cortex maturation and cognitive function. The $1,383,618 award, effective from January 1, 2025 to November 30, 2029, will fund research to investigate how cannabis-induced changes in microglia contribute to aberrant maturation of the medial prefrontal cortex and impaired executive...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
This Project Grant award from the Health Resources and Services Administration (HRSA) under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) will fund a research project to examine cannabis communication during prenatal care visits and its association with maternal and neonatal health outcomes.
The $356,829 award to Towson University will: (1) analyze variations in cannabis communication received by pregnant women across states and over time, including differences by maternal characteristics and social determinants of health; (2) examine the relationship between cannabis communication and perinatal outcomes like prenatal cannabis use and neonatal health; and (3) assess the impact of the COVID-19 pandemic on maternal cannabis use, maternal health, and cannabis communication during prenatal visits. The researchers will use data from the CDC's Pregnancy Risk Assessment Monitoring System (PRAMS) and plan to disseminate their findings through peer-reviewed publications and conference presentations.